Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioNTech SE Director's Dealing 2026

Mar 25, 2026

30236_dirs_2026-03-25_ef691368-d6bc-4be6-be13-55992a3e4dad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

EX-24 2 powerofattorneyrzg.htm EX-24 Document created using Wdesk Copyright 2026 Workiva Document

LIMITED POWER OF ATTORNEY

FOR SEC REPORTING OBLIGATIONS

Know all by these presents, that the undersigned hereby makes, constitutes and appoints each of

Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari, signing singly and each acting

individually, as the undersigned’s true and lawful attorney-in-fact with full power and authority as

hereinafter described to:

(1) submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID Application

and/or Passphrase Update Application or any other application materials to enable the undersigned

to gain or maintain access to the Electronic Data Gathering, Analysis and Retrieval system of the

SEC;

(2) take any other action of any type whatsoever in connection with the foregoing which, in the

opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by,

the undersigned, it being understood that the documents executed by such attorney-in-fact on

behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and

shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-

fact’s discretion;

(3) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or

director of BioNTech SE (the “Company”), filings under Section 16 of the Securities Exchange

Act of 1934, Forms 144, and Schedules 13D and 13G, each including any amendments thereto;

(4) do and perform any and all acts for and on behalf of the undersigned which may be necessary

or desirable to prepare, complete and execute any such filings, prepare, complete and execute any

amendment or amendments thereto, and timely deliver and file such form with the SEC and any

stock exchange or similar authority; and

(5) seek or obtain, as the undersigned’s representative and on the undersigned’s behalf, information

regarding transactions in the Company’s securities from any third party, including brokers,

employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such

person to release any such information to such attorney-in-fact and approves and ratifies any such

release of information.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and

perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the

exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the

undersigned might or could do if personally present, with full power of substitution or revocation,

hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute

or substitutes, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney

and the rights and powers herein granted. The undersigned acknowledges that the foregoing

attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming

nor relieving, nor is the Company assuming nor relieving, any of the undersigned’s responsibilities

to comply with filing obligations pursuant to Form 144, Schedule 13D, Schedule 13G, Form 3,

Form 4, or Form 5. The undersigned acknowledges that neither the Company nor the foregoing

attorneys-in-fact assume (i) any liability for the undersigned’s responsibility to comply with the

beneficial ownership and transaction reporting requirements associated with the foregoing filings

or (ii) any liability of the undersigned for any failure to comply with such requirements.

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no

longer required to file any such with respect to the undersigned’s beneficial ownership of and

transactions in securities issued by the Company, unless earlier revoked by the undersigned in a

signed writing delivered to the foregoing attorneys-in-fact.

[Signature page follows.]

IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be

executed as of this 12 day of February, 2026.

/s/ Ramon Zapata Gomez

Name: Ramon Zapata Gomez

[Signature Page to Power of Attorney]

File No. 713 /2025 D.

I hereby certify, that the above signature are the true signature, subscribed in

my presence, of

Mr. Ramon Zapata Gomez,

born [***],

business adress: 55131 Mainz, An der Goldgrube 12

  • personally known to me –

Upon my inspection of today of the commercial register, I certify that

BioNTech SE

is registered at the Municipal Court of Mainz - Commercial Register - under No. HRB

48720 and that

Mr. Ramon Zapata Gomez, born [***],

as this company's Management Board Member,

are registered with the right to jointly act as this company' s legal representatives.

Mainz, 12th of February 2026

[SEAL]

/s/ Mascha Diefenbach

Diefenbach, Notary public

26D0713.docx

[SEAL]

APOSTILLE

(Convention de La Haye du 5 octobre 1961)

  1. Country: Federal Republic of Germany

This public document

  1. has been signed by Mascha Diefenbach

  2. acting in the capacity of notary public

  3. bears the seal/stamp of Mascha Diefenbach - Notarin in Mainz

Certified

  1. at Mainz 6. the 25.02.2026

  2. by the President of the District Court

  3. No 249/2026

  4. Stamp: [SEAL] 10. Signature:

/s/ Thomas Bergmann

Thomas Bergmann